Abstract
Clinical practice guidelines are systematically developed statements designed to assist practitioners in making decisions about appropriate healthcare for specific clinical circumstances. Their successful implementation should improve quality of care by decreasing inappropriate variation and expediting the application of effective advances to everyday practice. Despite wide promulgation, guidelines have had limited effect on changing physician behaviors. This two-part review article highlights variations in the current recommended management of lymphoma (Part I) and leukemia (Part II), with some focus on targeted therapies. Focus on variations that may be amenable to educational programs designed for physicians were also considered in the review. For the purpose of this report, variation is defined as any deviation in the treatment or management of a particular hematologic malignancy where practice guidelines exist. Specific studies that demonstrate factors that may cause variations in clinical outcomes of hematologic malignancies and may contribute to variations in practice are featured.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2449-2456 |
| Number of pages | 8 |
| Journal | Leukemia and Lymphoma |
| Volume | 55 |
| Issue number | 11 |
| DOIs | |
| State | Published - Nov 1 2014 |
Fingerprint
Keywords
- Leukemia
- Lymphoma
- Practice variation
ASJC Scopus subject areas
- Hematology
- Oncology
- Cancer Research
Cite this
Insights on practice variations in the management of lymphoma and leukemia. / Loberiza, Fausto R.; Cannon, Andrew C.; Cannon, Anthony J.; Bierman, Philip Jay.
In: Leukemia and Lymphoma, Vol. 55, No. 11, 01.11.2014, p. 2449-2456.Research output: Contribution to journal › Review article
}
TY - JOUR
T1 - Insights on practice variations in the management of lymphoma and leukemia
AU - Loberiza, Fausto R.
AU - Cannon, Andrew C.
AU - Cannon, Anthony J.
AU - Bierman, Philip Jay
PY - 2014/11/1
Y1 - 2014/11/1
N2 - Clinical practice guidelines are systematically developed statements designed to assist practitioners in making decisions about appropriate healthcare for specific clinical circumstances. Their successful implementation should improve quality of care by decreasing inappropriate variation and expediting the application of effective advances to everyday practice. Despite wide promulgation, guidelines have had limited effect on changing physician behaviors. This two-part review article highlights variations in the current recommended management of lymphoma (Part I) and leukemia (Part II), with some focus on targeted therapies. Focus on variations that may be amenable to educational programs designed for physicians were also considered in the review. For the purpose of this report, variation is defined as any deviation in the treatment or management of a particular hematologic malignancy where practice guidelines exist. Specific studies that demonstrate factors that may cause variations in clinical outcomes of hematologic malignancies and may contribute to variations in practice are featured.
AB - Clinical practice guidelines are systematically developed statements designed to assist practitioners in making decisions about appropriate healthcare for specific clinical circumstances. Their successful implementation should improve quality of care by decreasing inappropriate variation and expediting the application of effective advances to everyday practice. Despite wide promulgation, guidelines have had limited effect on changing physician behaviors. This two-part review article highlights variations in the current recommended management of lymphoma (Part I) and leukemia (Part II), with some focus on targeted therapies. Focus on variations that may be amenable to educational programs designed for physicians were also considered in the review. For the purpose of this report, variation is defined as any deviation in the treatment or management of a particular hematologic malignancy where practice guidelines exist. Specific studies that demonstrate factors that may cause variations in clinical outcomes of hematologic malignancies and may contribute to variations in practice are featured.
KW - Leukemia
KW - Lymphoma
KW - Practice variation
UR - http://www.scopus.com/inward/record.url?scp=84912081397&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84912081397&partnerID=8YFLogxK
U2 - 10.3109/10428194.2014.881480
DO - 10.3109/10428194.2014.881480
M3 - Review article
C2 - 24410589
AN - SCOPUS:84912081397
VL - 55
SP - 2449
EP - 2456
JO - Leukemia and Lymphoma
JF - Leukemia and Lymphoma
SN - 1042-8194
IS - 11
ER -